William B. Slayton - Concepedia

Author

William B. Slayton

Also Known As

Petr Starostik, W B Slayton, W Slayton, W. Slayton, W.B. Slayton, WILLIAM B. SLAYTON, WILLIAM SLAYTON, William B Slayton, William B Slayton,, William B. Slayton

149

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

University of Florida Florida College University of Florida Health University of Utah BC Children's Hospital

About

William B. Slayton is an author at University of Florida specializing in medicine, hematology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	20	1.3K
2	Health Sciences	10	10	566
3	Public Health	1	1	12
4	Allergy	1	1	20
5	Blood Transplantation	1	1	242

William B. Slayton

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study Kirk R. Schultz, W. Paul Bowman, Alexander Aledo, Journal of Clinical Oncology	2009	700
Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031 Kirk R. Schultz, Andrew J. Carroll, Nyla A. Heerema, Leukemia Hematological MalignancyPediatric HematologyMedicineHematologyPediatrics	2014	442
Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Results of Children’s Oncology Group Trial AALL0622 William B. Slayton, Kirk R. Schultz, John A. Kairalla, Journal of Clinical Oncology Young AdultsContinuous ImatinibMyeloid NeoplasiaHematological MalignancyNeuro-oncology	2018	242
High incidence of epithelial cancers in mice deficient for DNA polymerase δ proofreading Robert E. Goldsby, Laura E. Hays, Xin Chen, Proceedings of the National Academy of Sciences	2002	171
Use of Alternative Therapies for Children With Cancer Tracey Friedman, William B. Slayton, Linda S. Allen, PEDIATRICS	1997	153
Involved-Node Proton Therapy in Combined Modality Therapy for Hodgkin Lymphoma: Results of a Phase 2 Study Bradford S. Hoppe, Stella Flampouri, Robert Zaiden, International Journal of Radiation OncologyBiologyPhysics	2014	68
Bone marrow sinusoidal endothelial cells undergo nonapoptotic cell death and are replaced by proliferating sinusoidal cells in situ to maintain the vascular niche following lethal irradiation Xiaomiao Li, Zhongbo Hu, Marda L. Jorgenson, Experimental Hematology Regenerative MedicineLethal IrradiationAngiogenesisBone Marrow FailureMedicine	2008	64
Conditional Deletion of Jak2 Reveals an Essential Role in Hematopoiesis throughout Mouse Ontogeny: Implications for Jak2 Inhibition in Humans Sung O Park, Heather L. Wamsley, Kyung‐Mi Bae, PLoS ONE Conditional Jak2 DeletionImmunologyBlood CellCell DeathEmbryology	2013	63
The Role of the Donor in the Repair of the Marrow Vascular Niche Following Hematopoietic Stem Cell Transplant William B. Slayton, Xiaomiao Li, Jason M. Butler, Stem Cells ImmunologyBlood CellRegenerative MedicineBone Marrow FailureMarrow Sinusoids	2007	60
Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients Rohit Bishnoi, Ravneet Bajwa, Aaron J Franke, Experimental Hematology and Oncology	2017	58

Page 1